Home Newsfeeds Nutanix Explores Sale After Receiving Takeover Interest, Sources Say

Nutanix Explores Sale After Receiving Takeover Interest, Sources Say

-Wall Street Journal https://www.wsj.com/articles/nutanix-explores-sale-after-receiving-takeover-interest-11665739802

byCharles Gross

October 14, 2022

1 minute read

-Wall Street Journal

https://www.wsj.com/articles/nutanix-explores-sale-after-receiving-takeover-interest-11665739802

Stifel Upgrades Verve Therapeutics to Buy, Raises Price Target to $56

By Benzinga Newsdesk

August 25, 5:02 AM

Stifel analyst Dae Gon Ha upgrades Verve Therapeutics (NASDAQ:VERV) from Hold to Buy and raises the price target from $32 to $56.

VERV

This Analyst With 86% Accuracy Rate Sees More Than 24% Upside In Lattice Semiconductor – Here Are 5 Stock Picks For April From Wall Street’s Most Accurate Analysts

By Avi Kapoor

May 1, 7:20 AM

U.S. stocks settled lower on Tuesday, with the Dow Jones index dipping more than 550 points during the…

DPZ

EVgo Reports Mixed Q2 Results

By Shivani Kumaresan

August 9, 12:19 PM

EVgo Inc (NASDAQ:EVGO) reported second-quarter FY22 sales growth of 90% year-on-year to $9.08 million, missing the consensus of $10.81 million. EVgo’s…

EVGO

Why Paratek Pharmaceuticals Stock Is Up Today

By Ryan Gustafson

June 6, 3:38 PM

Shares of Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company, are up Tuesday after the company announced that it entered into a definitive agreement to be acquired by Gurnet Point Capital and Novo

PRTK

Nutanix Explores Sale After Receiving Takeover Interest, Sources Say

Related Posts

Stifel Upgrades Verve Therapeutics to Buy, Raises Price Target to $56

This Analyst With 86% Accuracy Rate Sees More Than 24% Upside In Lattice Semiconductor – Here Are 5 Stock Picks For April From Wall Street’s Most Accurate Analysts

EVgo Reports Mixed Q2 Results

Why Paratek Pharmaceuticals Stock Is Up Today